Neisseria Meningitidis Disease
📧 Sign up to get email alerts when something new happens for Neisseria Meningitidis Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-03-28Clinical Trial Update: Immunogenicity and Safety of V419 (PR51) in Combination With MCC in Infants and Toddlers (V419-011) [Phase 3]
Phase 3 trial update on immunogenicity and safety of V419 (PR51) in combination with MCC in infants and toddlers; completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2018-08-24Clinical Trial Update: Immunogenicity and Reactogenicity of a Meningococcal B Outer Membrane Vesicle Vaccine Given in a 0,6,12 Month Schedule to Health UK Adults [Phase 2]
Phase 2 trial update evaluating immunogenicity and reactogenicity of a meningococcal B outer membrane vesicle vaccine in a 0,6,12 month sche…
-
CLINICAL_TRIALS trial_result · 2017-09-11Clinical Trial Update: Concomitant Administration of a New Hexavalent Vaccine With a Meningococcal Serogroup C Conjugate Vaccine in Healthy Infants During Primary Series Immunisation Followed by Booster Vaccination [Phase 3]
A Phase 3 trial evaluated concomitant administration of a new hexavalent vaccine with a meningococcal serogroup C vaccine in healthy infants…
-
CLINICAL_TRIALS trial_result · 2014-08-15Clinical Trial Update: Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine in Healthy Infants [Phase 2]
Phase 2 trial of GSK2202083A vaccine in healthy infants completed; multiple conditions tested including tetanus, hepatitis B, Hib, polio, ac…
-
CLINICAL_TRIALS trial_result · 2013-12-30Clinical Trial Update: Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine [Phase 2]
Phase 2 trial comparing Hib-MenCY-TT vaccine to licensed Hib conjugate or meningococcal vaccine; study completed with results posted in 2013…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-07-23Clinical Trial Update: 3 Formulations of Hib-MenCY-TT Vaccine & 1 Formulation of Hib-MenC-TT Vaccine Compared to Licensed Meningococcal Serogroup C Conjugate Vaccine, Each Administered at 2,3,4 Mths of Age [Phase 2]
A Phase 2 trial comparing multiple Hib-MenCY-TT and Hib-MenC-TT vaccine formulations to a licensed meningococcal vaccine in infants aged 2-4…
-
CLINICAL_TRIALS trial_result · 2010-12-23Clinical Trial Update: Persistence of Antibodies at 3, 4 and 6 Years of Age After Vaccination With Meningococcal, Pneumococcal and Hib Vaccines [Phase 3]
Phase 3 trial update reporting long-term antibody persistence after vaccination with meningococcal, pneumococcal, and Hib vaccines in childr…
-
CLINICAL_TRIALS trial_result · 2009-10-23Clinical Trial Update: Study in Toddlers to Demonstrate Non-inferiority of GSK Biologicals' Hib-MenC & to Evaluate Persistence up to 5 Years. [Phase 3]
Phase 3 clinical trial update assessing non-inferiority and 5-year persistence for GSK Hib-MenC in toddlers across Haemophilus influenzae ty…